MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MicroRNA-194 is a Marker for Good Prognosis in Clear Cell Renal Cell Carcinoma
Authors
Keywords
-
Journal
Cancer Medicine
Volume 5, Issue 4, Pages 656-664
Publisher
Wiley
Online
2016-02-10
DOI
10.1002/cam4.631
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Low Expression of miR-126 Is a Prognostic Marker for Metastatic Clear Cell Renal Cell Carcinoma
- (2015) Heba W.Z. Khella et al. AMERICAN JOURNAL OF PATHOLOGY
- Cytoskeletal signaling in TGFβ-induced epithelial-mesenchymal transition
- (2015) Sandeep M. Nalluri et al. Cytoskeleton
- Profilin-1 expression is associated with high grade and stage and decreased disease-free survival in renal cell carcinoma
- (2015) Jason R. Karamchandani et al. HUMAN PATHOLOGY
- miR-210 Is a Prognostic Marker in Clear Cell Renal Cell Carcinoma
- (2015) Sara Samaan et al. JOURNAL OF MOLECULAR DIAGNOSTICS
- PIK3R1 negatively regulates the epithelial-mesenchymal transition and stem-like phenotype of renal cancer cells through the AKT/GSK3β/CTNNB1 signaling pathway
- (2015) Youcheng Lin et al. Scientific Reports
- Comparison of clinicopathological parameters with FoxM1 expression in renal cell carcinoma
- (2015) Sezen Kocarslan et al. Journal of Cancer Research and Therapeutics
- MicroRNA-194 Inhibits the Epithelial–Mesenchymal Transition in Gastric Cancer Cells by Targeting FoxM1
- (2014) Zhenjun Li et al. DIGESTIVE DISEASES AND SCIENCES
- Development of renal cell carcinoma (RCC) diagnostics and impact on prognosis
- (2013) Kaisa L. Sunela et al. BJU INTERNATIONAL
- miR-192, miR-194 and miR-215: a convergent microRNA network suppressing tumor progression in renal cell carcinoma
- (2013) H.W.Z. Khella et al. CARCINOGENESIS
- Genomic Medicine: New Frontiers and New Challenges
- (2013) M. D. Pasic et al. CLINICAL CHEMISTRY
- miR-192, miR-194, miR-215, miR-200c and miR-141 are downregulated and their common target ACVR2B is strongly expressed in renal childhood neoplasms
- (2012) U. Senanayake et al. CARCINOGENESIS
- Identification of Metastamirs as Metastasis-associated MicroRNAs in Clear Cell Renal Cell Carcinomas
- (2012) Zofia Wotschofsky et al. International Journal of Biological Sciences
- Identification of a 4-microRNA Signature for Clear Cell Renal Cell Carcinoma Metastasis and Prognosis
- (2012) Xiwei Wu et al. PLoS One
- miRNA profiling in metastatic renal cell carcinoma reveals a tumour-suppressor effect for miR-215
- (2011) N M A White et al. BRITISH JOURNAL OF CANCER
- Epigenetic biomarkers in urological tumors: A systematic review
- (2011) Carmen Jerónimo et al. CANCER LETTERS
- Accurate Molecular Classification of Kidney Cancer Subtypes Using MicroRNA Signature
- (2011) Youssef M. Youssef et al. EUROPEAN UROLOGY
- The Epidemiology of Renal Cell Carcinoma
- (2011) Börje Ljungberg et al. EUROPEAN UROLOGY
- miRNA Profiling for Clear Cell Renal Cell Carcinoma: Biomarker Discovery and Identification of Potential Controls and Consequences of miRNA Dysregulation
- (2011) Nicole M.A. White et al. JOURNAL OF UROLOGY
- MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1
- (2011) Peixin Dong et al. Molecular Cancer
- Exploring the role of miRNAs in renal cell carcinoma progression and metastasis through bioinformatic and experimental analyses
- (2011) Heba W. Z. Khella et al. TUMOR BIOLOGY
- Downregulation of p53-inducible microRNAs 192, 194, and 215 Impairs the p53/MDM2 Autoregulatory Loop in Multiple Myeloma Development
- (2010) Flavia Pichiorri et al. CANCER CELL
- miR-194 is a marker of hepatic epithelial cells and suppresses metastasis of liver cancer cells in mice
- (2010) Zhipeng Meng et al. HEPATOLOGY
- MicroRNAs in Cancer
- (2009) Ramiro Garzon et al. Annual Review of Medicine
- MicroRNA function in cancer: oncogene or a tumor suppressor?
- (2009) Sylvia K. Shenouda et al. CANCER AND METASTASIS REVIEWS
- Prognostic Factors for Overall Survival in Patients With Metastatic Renal Cell Carcinoma Treated With Vascular Endothelial Growth Factor–Targeted Agents: Results From a Large, Multicenter Study
- (2009) Daniel Y.C. Heng et al. JOURNAL OF CLINICAL ONCOLOGY
- p53-Responsive MicroRNAs 192 and 215 Are Capable of Inducing Cell Cycle Arrest
- (2008) C. J. Braun et al. CANCER RESEARCH
- Epidemiologic and socioeconomic burden of metastatic renal cell carcinoma (mRCC): A literature review
- (2008) Kiran Gupta et al. CANCER TREATMENT REVIEWS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search